Z

Zoetis Services

Develops, manufactures, and sells animal vaccines

Quality Control Manager

Full-TimeDeadline 12/28/26
No salary listed
Expert
Bachelor's, Master's, MBA
Charles City, VA, USA
In Person
Biology & BiotechRegulatory & Quality (Life Sciences)
H1B Sponsorship Available

About the job

Requirements
  • A Bachelor of Science or Bachelor of Arts degree in a science-related field with 9–13 years of experience, or a Master of Science or Master of Business Administration degree in a science-related field with 7–11 years of experience.
  • Proficiency in Microsoft Word, Excel, and PowerPoint, including advanced features for data analysis, reporting, and presentation development.
  • Familiarity with statistical analysis and strong problem-solving skills.
  • Strong technical writing skills.
  • Knowledge of United States Department of Agriculture, European Union, and Animal Welfare Act guidelines.
  • Ability to work scheduled 40 hours, overtime as needed, weekends as needed, and rotating weekend duties.
  • Ability to perform the stated physical tasks, including prolonged walking, sitting, or standing; reaching, bending, stooping, kneeling, pushing, pulling, gripping, lifting, carrying, twisting, and repetitive wrist, hand, and finger movements.
  • Ability to grasp and manipulate objects such as pipettors, flasks, and bottles.
  • All applicants must possess or obtain authorization to work in the United States.
Responsibilities
  • Manage all Biological Quality Control Operations for the Charles City site to ensure vaccines meet United States, European Union, and international regulatory requirements.
  • Advise management of products that do not meet required testing specifications and recommend appropriate regulatory actions.
  • Oversee day-to-day activities in the Quality Control laboratories and Animal Test facility.
  • Manage the Virology; Bacteriology and Immunology; Chemistry, Microbiology and Environmental Monitoring; and Animal Test departments.
  • Assure the overall quality and integrity of biological products manufactured and distributed in worldwide markets based on 9 CFR, applicable current Good Manufacturing Practice regulations, and industry standards.
  • Ensure biological products manufactured by or distributed by Charles City are tested according to applicable United States Department of Agriculture, European Union, Zoetis, and destination-country requirements.
  • Manage Animal and Plant Health Inspection Service sampling, Animal and Plant Health Inspection Service Form 2008 preparation, stability and confirmation of expiry testing and submissions, Laboratory Information Management System management, and test sample distribution.
  • Ensure colleagues are adequately trained and continue receiving training on current Good Manufacturing Practices, safety, Occupational Safety and Health Administration requirements, technical skills, policies, and procedures.
  • Ensure training documentation is accurate and only trained colleagues perform assigned functions.
  • Use situational leadership skills, encourage participation and teamwork, develop people, conduct performance appraisals, create an inclusive environment, and promote mutual accountability.
  • Provide leadership for the Quality Operations Quality Control unit.
  • Direct the review of and provide Quality Control approval for test records, batch records, process worksheets, standard methods, and standard operating procedures.
  • Ensure testing and manufacturing documents follow Outlines of Production.
  • Review and approve validation protocols and task reports as necessary.
  • Work with Quality Control laboratory personnel, Manufacturing, and Planning to organize and prioritize schedules for timely testing and release of saleable, experimental, stability, and transfer products.
  • Work with Biological Manufacturing management to investigate and resolve processing quality and compliance issues through appropriate and timely testing.
  • Participate in key teams and task forces and make recommendations to maintain regulatory compliance at Charles City.
  • Participate in regulatory inspections of the Charles City facility.
  • Manage systems supporting raw material release, final product release, new product transfers and specifications, annual product reviews, stability, and complaints.
  • Ensure quality documentation used in the manufacture and testing of biological products meets current Good Manufacturing Practice and regulatory requirements.
  • Establish systems to maintain audit readiness of testing documentation for regulatory agencies and internal auditors.
  • Implement communication networks for information flow among plant sites, senior management, staff groups, and regulatory agencies.
  • Ensure compliance between current testing practices and regulatory filings through a regulatory compliance self-inspection program.
  • Support location and site leadership initiatives.
  • Monitor changes in the external regulatory community.

About the company

Zoetis creates medicines and vaccines to protect the health of companion animals and livestock. Its products include vaccines, anti-infectives, parasiticides, dermatology and other therapeutics, medicated feed additives, and diagnostics, sold through veterinarians, livestock producers, and pet owners. The company reaches customers in more than 100 countries and relies on big R&D and a global marketing network to bring new solutions to market. Its goal is to improve animal health worldwide by delivering science-based products and services that help care for animals and prevent disease.

Company Size

10,001+

Company Stage

IPO

Headquarters

Parsippany-Troy Hills, New Jersey

Founded

1952

Get referred to Zoetis Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA granted Simparica Trio EUA on August 13, 2026 for screwworm in dogs.
  • Livestock revenue grew double digits in 2026, led by cattle, poultry, and fish.
  • Lenivia and Portela launches in Canada and Europe expand osteoarthritis pain coverage.

What critics are saying

  • U.S. companion-animal revenue fell 7% in Q2 2026 as clinic visits weakened.
  • Elanco and Merck are squeezing Apoquel and Simparica with promotions through 2027.
  • If dermatology share keeps eroding, Zoetis becomes a slower livestock-and-diagnostics utility.

What makes Zoetis Services unique

  • Zoetis dominates veterinary channels with a broad companion-animal and livestock portfolio.
  • Its pipeline spans renal disease, oncology, cardiology, and dermatology, unlike commodity peers.
  • Global reach across 100-plus countries gives Zoetis pricing power and distribution leverage.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

13%

1 year growth

15%

2 year growth

15%
Yahoo Finance
Oct 13th, 2026
Zoetis appoints Cannes Film Festival president Iris Knobloch to board, expanding it to 13 members

Zoetis has appointed Iris Knobloch to its board of directors, effective December 1, 2026. The appointment raises the animal health company's board from 12 to 13 members. Knobloch has been president of the Festival de Cannes since July 2022. She chairs the board of music streaming platform Deezer and also sits on the boards of Lazard and Vail Resorts. She previously held senior roles at WarnerMedia. Chief executive officer Kristin Peck said Knobloch's experience in consumer strategy, digital transformation, and regulatory environments will help as Zoetis explores new ways to connect with pet owners.

Pet Gazette
Oct 9th, 2026
Zoetis named in Fortune Europe's 100 Best Companies to Work for in 2026.

Zoetis named in Fortune Europe's 100 Best Companies to Work for in 2026. Animal health firm becomes the only sector specialist to feature in the 2026 European workplace rankings Latest Podcast Episode On this episode of Talking Shop Pet Gazette is joined by Scott Erickson, VP of Sales, US and Global Channels at HappyOrNot. HappyOrNot captures real-time, point-of-experience micro-feedback across thousands of global retail environments. Drawing on insights from their Q2 2026 Retail CX Pulse report, Scott joins Pet Gazette to challenge traditional ways of measuring customer satisfaction. Animal health company Zoetis has been named one of Fortune Europe's 100 Best Companies to Work for in 2026, becoming the only dedicated animal health company included on the list. The ranking is compiled by Great Place To Work and Fortune Europe using employee survey responses and information provided by companies on their workplace programmes and strategies. For the opportunity to appear on the list, companies are assessed on factors including trust in leadership, meaningful work, fairness in pay and promotion as well as opportunities for professional development. Zoetis' inclusion follows its recognition in national Best Workplace lists, which made the company eligible for the European ranking. Julia von Gablenz, regional president, Europe and Middle East, Zoetis said: "Zoetis is committed to supporting a workplace where colleagues can thrive and achieve their potential. I am incredibly proud that Zoetis has been recognised as a Fortune Best Company to Work For in Europe. "This achievement belongs to all of our colleagues, whose hard work, passion and commitment create the culture we are so proud of. Every day, in every role, colleagues drive our purpose and business forward. Being part of the list is a testament to Zoetis' inclusive and supportive workplace culture that promotes employee well-being, growth and collaboration." Published: 1h ago

Yahoo Finance
Oct 7th, 2026
Seven S&P 500 stocks need 200%+ rallies to reclaim all-time highs

Seven major S&P 500 companies with market capitalizations exceeding $20 billion need to rally at least 200% to reach their previous all-time highs, according to Bespoke. The struggling firms include PG&E, PayPal, Ford, Nike, Las Vegas Sands, Zoetis, and Crown Castle. Nike has experienced particularly poor performance, with the company's stock trading at record lows and its dividend yield approaching 5%. Recent quarterly results showed Nike Brand sales fell 4%, online sales dropped 13%, Converse sales declined 28%, and China sales crashed 26%. CEO Elliott Hill indicated that weakness in the sportswear market would persist. PayPal faces intense competition in the payments sector. New CEO Enrique Lores reportedly declined a buyout offer from Stripe and will focus on cost reductions and improving customer experience.

EDM Publications GmbH
Sep 22nd, 2026
CooperVision appoints new global director for global myopia management.

CooperVision appoints new global director for global myopia management. 22 September 2026 Chris Dimmack joins CooperVision as senior director, global myopia management, moving from Zoetis, where he was head of sales. He previously spent close to 18 years at Johnson & Johnson, most recently as commercial business manager. Jennifer Lambert, who held the same position at CooperVision, was promoted to the vice... Subscribe today. Buying a membership today will give you: * Unlimited access to ewintelligence.com - all insight and analysis available online * Its executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry * Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments * Case studies and best practices on business challenges * Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry * Access to over 11,500 articles and analyses in the archive * Personal library to save articles and track your key content * Powerful search and intuitive navigation * Organisation-wide access across offices, people and devices

Petnews Australia Pty Ltd
Sep 18th, 2026
The AVA secures $150,000 Zoetis Foundation grant.

The AVA secures $150,000 Zoetis Foundation grant. The Australian Veterinary Association (AVA) has received a USD $150,000 grant from the Zoetis Foundation to expand its Cultivating Safe Teams program nationwide. The funding will support the AVA's goal of training every veterinary professional in Australia to identify and manage psychosocial risks in the workplace. More than 1,300 veterinary professionals have completed the training since it launched in 2023. Cultivating Safe Teams is the flagship program under the AVA's THRIVE wellbeing initiative, which targets psychological harm in veterinary workplaces. Dr Diana Barker, President of the AVA, said the grant would allow the organisation to broaden the program's reach. "Veterinary teams do extraordinary work under real pressure, and for too long the toll of that pressure has gone unaddressed. "This grant enables us to take a program that works and put it in front of every veterinary professional in the country." The program grew out of the AVA's 2021 Veterinary Stakeholder Wellness Survey, which found two in three veterinary professionals had experienced a mental health condition, and almost half said their work was harming their mental health. Cultivating Safe Teams runs as a one-hour awareness session built around evidence-based workplace psychological health and safety frameworks, designed to fit around busy clinic schedules. Among participants, 93 per cent rated the session useful and 94 per cent rated it relevant, while confidence in identifying psychosocial hazards rose by 60 per cent. Dr Barker explained that proactive management of psychosocial risk is now the law in every Australian jurisdiction, so there has never been a more important time to act. "This is about more than compliance. It is about building workplaces where people are safe, supported and want to stay, and that is good for our people, our patients and the future of the profession." The AVA is now expanding the program beyond awareness-raising with a new offering, CST ACTION, which trains workplace champions to run a validated risk assessment and design initiatives tailored to their own hazard profile. The offering includes coaching from organisational psychologists, self-paced modules and peer-to-peer learning. Expressions of interest for the 2027 program are open now on the AVA website. Jeannette Ferran Astorga, Executive Vice President of Corporate Affairs at Zoetis and President of the Zoetis Foundation, said the funding reflected the company's commitment to the sector. "The veterinary profession is foundational to animal health, and the professionals caring for animals deserve workplaces that protect their wellbeing. "We are proud to support the AVA in scaling a program that is already making a measurable difference to veterinary teams across Australia." Cultivating Safe Teams is delivered with support from the Zoetis Foundation, Crampton Consulting Group, Hill's Pet Nutrition and Troy.